Merck & Company (MRK) - down against buyback and +161.5%
If you have already purchased a subscription, log in to our website.
If you don't want to purchase a subscription, you can also order to view one or more articles without having to purchase a subscription. To access this news, you need to purchase a subscription Analytics and forecasts 42$.
